Antiatherogenic effect of isoflavones in ovariectomized apolipoprotein E-deficient mice

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 22, 2007, Pages 8967-8971

  Sato, Masao ^a   Sato, Hiroyoshi ^a   Ogawa, Akiko ^a   Nomura, Run ^a   Takashima, Shinichiro ^a   Bang, Hyun Jung ^a   Matsuoka, Hiromi ^a   Imaizumi, Katsumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E deficient mice; Isoflavone; Monocyte chemoattractant protein I; Nitric oxide; Ovariectomy; Peritoneal macrophages

Indexed keywords

APOLIPOPROTEIN E; ISOFLAVONE DERIVATIVE;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; FEMALE; MOUSE; OVARIECTOMY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FEMALE; ISOFLAVONES; MICE; OVARIECTOMY;

GLYCINE MAX; MUS;

EID: 36148929869     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf071771q     Document Type: Article

References (35)

1. Stampfer, M. J.; Colditz, G. A. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev. Med. 1991, 20, 47-63.
2. Nestel, P. Isoflavones: their effects on cardiovascular risk and functions. Curr. Opin. Lipidol. 2003, 14, 3-8.
3. Ni, W.; Tsuda, Y.; Sakono, M.; Imaizumi, K. Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J. Nutr. 1998, 128, 1884-1889.
4. Adams, M. R.; Golden, D. L.; Register, T. C.; Anthony, M. S.; Hodgin, J. B.; Maeda, N.; Williams, J. K. The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-α. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1859-1864.
5. Yamakoshi, J.; Piskula, M. K.; Izumi, T.; Tobe, K.; Saito, M.; Kataoka, S.; Obata, A.; Kikuchi, M. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J. Nutr. 2000, 130, 1887-1893.
6. Adams, M. R.; Golden, D. L.; Anthony, M. S.; Register, T. C.; Williams, J. K. The inhibitory effect of soy protein isolate in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins. J. Nutr. 2002, 132, 43-49.
7. Anthony, M. S. Soy and cardiovascular disease: cholesterol lowering and beyond. J. Nutr. 2000, 130, 662S-663S.
8. Tikkanen, M. J.; Wahala, K.; Ojala, S.; Vihma, V.; Adlercreutz, H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 3106-3110.
9. Wiseman, H.; O'Reilly, J. D.; Adlercreutz, H.; Mallet, A. I.; Bowey, E. A.; Rowland, I. R.; Sanders, T. A. Isoflavone phytoestrogens consumed in soy decrease F2-isoflavone concentrations and increase resistance of low density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 2000, 72, 395-400.
10. Bourassa, P. A.; Milos, P. M.; Gaynor, B. J.; Breslow, J. L.; Aiello, R. J. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 10022-10027.
11. King, R. A.; Broadbent, J. L.; Head, R. J. Absorption and excretion of the soy isoflavone genistgein in rats. J. Nutr. 1996, 126, 176-182.
12. Matsushima, K.; Larsen, C. G.; DuBois, G. C.; Oppenheim, J. J. Purification and characterization of a novel monocyte chemoatactic and activating factor produced by a human monocytic cell line. J. Exp. Med. 1989, 169, 1485-1490.
13. Kuhlencordt, P. J.; Chen, J.; Han, F.; Astern, J.; Huang, P. L. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 2001, 103, 3099-3104.
14. Sheu, F.; Lai, H.-H.; Yen, G.-C. Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages. J. Agric. Food Chem. 2001, 49, 1767-1772.
15. Behr-Roussel, D.; Rupin, A.; Simonet, S.; Bonhomme, E.; Coumailleau, S.; Cordi, A.; Serkiz, B.; Fabiani, J.-N.; Verbeuren, T. J. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 2000, 102, 1033-1038.
16. Tomoyori, H.; Kawata, Y.; Higuchi, T.; Ichi, I.; Sato, H.; Sato, M.; Ikeda, I.; Imaiumi, K. Phytosterol oxidation products are absorbed in the intestinal lymphatics in rats but do not accelerate atherosclerosis in apolipoprotein E-deficient mice. J. Nutr. 2004, 134, 1690-1696.
17. Fuhrman, B.; Rosenblat, M.; Hayek, T.; Coleman, R.; Aviram, M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr. 2000, 130, 1124-1131.
18. Ni, W.; Tsuda, Y.; Takashima, S.; Sato, H.; Sato, M.; Imaizumi, K. Anti-atherogenic effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice. Br. J. Nutr. 2003, 90, 13-20.
19. Sato, M.; Shibata, K.; Nomura, R.; Kawamoto, D.; Nagamine, R.; Imaizumi, K. Linoleic acid-rich fats reduce atherosclerosis development beyond its oxidative and inflammatory stress-increasing effect in apolipoprotein E-deficient mice in comparison with saturated fatty acid-rich fats. Br. J. Nutr. 2005, 94, 896-901.
20. Kawahara, R. S.; Deng, Z. W.; Deuel, T. F. Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene. J. Biol. Chem. 1991, 266, 13261-13266.
21. Adams, M. R.; Kaplan, J. R.; Manuck, S. B.; Koritnik, D. R.; Parks, J. S.; Wolfe, M. S.; Clarkson, T. B. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariecotmized monkeys. Arteriosclerosis 1990, 10, 1051-1057.
22. Haarbo, J.; Leth-Espensen, P.; Stender, S.; Christiansen, C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J. Clin. Invest. 1991, 87, 1274-1279.
23. Kuiper, G. G.; Carlsson, J. M.; Grandien, K.; Enmark, E.; Haggblad, J.; Nilssen, S.; Gustafsson, J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138, 863-870.
24. Setchell, K. D.; Brown, N. M.; Desai, P.; Zimmer-Nechemias, L.; Wolfe, B. E.; Brashear, W. T.; Kirschner, A. S.; Cassidy, A.; Heub, J. E. Bioavailability of pure isoflavones in healthy humans and analysis of commerchial soy product supplementats. J. Nutr. 2001, 131, 1362S-1375S.
25. Sathyamoorthy, N.; Wang, T. T. Differential effects of dietary daidzein and equol on human breast cancer MCF-7 cells. Eur. J. Cancer 1997, 33, 2384-2389.
26. Holder, C. L.; Churchwell, M. I.; Doerge, D. R. Quantification of soy isoflavones, genistein and daidzein, and conjugates in rat blood using LC/ES-MS. J. Agric. Food Chem. 1999, 47, 3764-3770.
27. Gottstein, N.; Ewins, B. A.; Eccleston, C.; Hubbard, G. P.; Kavanagh, I. C.; Minihane, A. M.; Weinberg, P. D.; Rimbach, G. Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br. J. Nutr. 2003, 89, 607-616.
28. MacMicking, J.; Xie, Q.-W.; Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15, 323-350.
29. Luoma, J. S.; Strälin, P.; Marklund, S. L.; Hiltunen, T. P.; Särkioja, T.; Ylä-Herttuala, S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 157-167.
30. Ischiropoulos, H.; Zhu, L.; Beckman, J. S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 1992, 298, 446-451.
31. Detmers, P. A.; Hernandez, M.; Mudgett, J.; Hassing, H.; Burton, C.; Mundt, S.; Chun, S.; Fletcher, D.; Card, D. J.; Lisnock, J.; Weikel, R.; Bergstrom, J. D.; Shevell, D. E.; Hermanowski-Vosatka, A.; Sparrow, C. P.; Chao, Y. S.; Rader, D. J.; Wright, S. D.; Pure, E. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J. Immunol. 2000, 165, 3430-3435.
32. Kuhlencordt, P. J.; Chen, J.; Han, F.; Astern, J.; Huang, P. L. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 2001, 103, 3099-3104.
33. Pervin, S.; Singh, R.; Rosenfeld, M. E.; Navab, M.; Chaudhuri, G.; Nathan, L. Estradiol suppresses MCP-1 expression In vivo: implications for atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1575-1582.
34. Kowala, M. C.; Recce, R.; Beyer, S.; Gu, C.; Valentine, M. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis 2000, 149, 323-330.
35. Boring, L.; Gosling, J.; Cleary, M.; Charo, I. F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394, 894-897.